Real-world experience with trabectedin for the treatment of recurrent ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world experience with trabectedin for the treatment of recurrent ovarian cancer

Published:2021-06-21 Issue:10 Volume:21 Page:1089-1095
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Romero Ignacio¹,López-Guerrero José Antonio²,Pignata Sandro³

Affiliation:

1. outpatient services, Fundación Instituto Valenciano De Oncología, Valencia, Spain

2. Laboratory of Molecular Biology, Fundación Instituto Valenciano De Oncología, Valencia, Spain

3. Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy

Funder

Pharmamar

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2021.1941890

Reference58 articles.

1. Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors

2. Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade

3. Progress in the Management of Gynecologic Cancer: Consensus Summary Statement

4. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

5. Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study;BMC Cancer;2024-07-05

2. Retrospective Multicenter Study of Elderly Patients With Platinum-Sensitive Relapsed Ovarian Cancer Treated With Trabectedin and Pegylated Liposomal Doxorubicin (Pld) in a Real- World Setting: A Geico Study;2024-04-16

3. Research progress on the role of tumor‑associated macrophages in tumor development and their use as molecular targets (Review);International Journal of Oncology;2023-12-07

4. Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study;Drugs - Real World Outcomes;2023-01-11

5. Trabectedin and lurbinectedin: Mechanisms of action, clinical impact, and future perspectives in uterine and soft tissue sarcoma, ovarian carcinoma, and endometrial carcinoma;Frontiers in Oncology;2022-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3